Intralesional laser therapy treatment for hemangiomas: Technical evolution
Intralesional laser therapy treatment for hemangiomas: Technical evolution
复制标题
DOI：
10.1097/00001665-200607000-00029
复制
发表时间：
2006-07-01
影响因子：
0.9
通讯作者：
Nahai, Farzad
中科院分区：
文献类型：
--
作者：
Burstein, Fernando D.;Williams, J. Kerwin;Nahai, Farzad
自1996年以来，作者已连续治疗了500多例患有巨大血管瘤（厚度超过10 mm）的儿科患者。所有患者均采用磷酸钛钾（KTP）激光进行病灶内激光治疗。自1996年开始KTP激光治疗深部血管瘤以来，作者对其治疗方案进行了重大修改。我们原始治疗方案的变化包括降低功率设置和缩短治疗间隔。此外，我们现在正在同时治疗深层成分，使用病灶内KTP激光，和浅表成分使用脉冲染料激光。通过在治疗深部成分期间注射少量稀释的类固醇溶液，与病灶内治疗相关的纤维化已大大减少。在保持手术疗效的同时，我们已经能够大大减少与之相关的并发症。作者详细介绍了他们目前的技术以及修改原始治疗方案的演变和理由。
The authors have treated over 500 consecutive pediatric patients with voluminous hemangiomas (thickness of over 10 mm), since 1996. They were all treated with intralesional laser therapy using the potassium, titanyl, phosphate (KTP) laser. Since the initiation of KTP laser therapy for deep hemangiomas in 1996, the authors have significantly modified their treatment regimen. Changes from our original treatment protocol include lower power settings, and decreased treatment intervals. Additionally, we are now simultaneously treating the deep component, using intralesional KTP laser, and the superficial component using a pulsed dye laser. Fibrosis associated with intralesional therapy has been greatly decreased by injecting small amounts of dilute steroid solution during treatment of the deep component. While maintaining the efficacy of the procedure, we have been able to greatly decrease complications associated with it. The authors detail their current techniques as well as the evolution and rationale for modifying the original treatment regimen.